President Donald Trump is reportedly nearing the end of negotiations with drugmakers Eli Lilly and Novo Nordisk to offer the lowest dose of their popular obesity drugs for $149 per month in exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback